# Healthcare Triangle, Inc.: Form 10-K/A for the period ended Dec 31, 2025

- Company: [Healthcare Triangle, Inc.](/companies/hcti.md) (CIK 1839285)
- Form: 10-K/A
- Filed: 2026-04-16
- Accepted by EDGAR: Apr 16, 2026, 16:47 ET
- Period: 2025-12-31
- Accession: 0001213900-26-044671
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1839285/000121390026044671/ea0286705-10ka1_healthcare.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1839285/000121390026044671/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2025-01-01 to 2025-12-31 | $13.9m | us-gaap:Revenues |
| Cost of revenue | 12 months, 2025-01-01 to 2025-12-31 | $12.0m | us-gaap:CostOfRevenue |
| Gross profit | 12 months, 2025-01-01 to 2025-12-31 | $1.24bn | us-gaap:GrossProfit |
| Research and development | 12 months, 2025-01-01 to 2025-12-31 | $536.0k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2025-01-01 to 2025-12-31 | −$9.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2025-01-01 to 2025-12-31 | $567.0k | us-gaap:InterestExpense |
| Net income | 12 months, 2025-01-01 to 2025-12-31 | −$9.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2025-01-01 to 2025-12-31 | −$152.30 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2025-01-01 to 2025-12-31 | −$152.30 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2025-01-01 to 2025-12-31 | 61,873 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2025-01-01 to 2025-12-31 | −$16.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2025-01-01 to 2025-12-31 | $6.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2025-12-31 | $7.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2025-12-31 | $13.2m | us-gaap:AssetsCurrent |
| Total assets | at 2025-12-31 | $22.7m | us-gaap:Assets |
| Current liabilities | at 2025-12-31 | $12.8m | us-gaap:LiabilitiesCurrent |
| Short-term borrowings | at 2025-12-31 | $10.7m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2025-12-31 | $9.9m | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1839285/000121390026044671/ea0286705-10ka1_healthcare.htm

Filed Apr 16, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-044671. Last ingested by Listed: Oct 27, 2026, 17:16 ET. No prices; not investment advice.